Clyde Biosciences

Clyde Biosciences specializes in cardiomyocyte assays through its CellOPTIQ platform, which provides human-relevant functional data for drug safety and efficacy. The company aims to facilitate faster and more accurate drug development while reducing costs and risks associated with cardiovascular liabilities. Clyde is recognized as the only validate... d contract research organization (CRO) for the CiPA Assay, offering a comprehensive suite of services including primary screening and mechanistic toxicity assays. Their clients include major pharmaceutical companies and regulatory agencies, reflecting their commitment to improving cardiac safety in drug discovery.Read More